CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
DiaSorin received funding from the Biomedical Advanced Research and Development Authority for the development, validation, FDA emergency use authorization, and submission of 510(k) clearance of the test.
The Liaison SARS-CoV-2 Ag runs on the company’s Liaison XL platform.
DiaSorin, 562-240-6500
Pages: 1 2